Skip to content
ResearchMONITOR
Log inStart free

A note for Elicit Alerts users

Moving off Elicit Alerts?

Written 5 October 2026. The dates come from Elicit's help article, linked below.

Elicit is retiring its legacy Alerts this month. If you used them to keep up with new papers, here is what is changing, what you can do before the cut-off, and where Research Monitor might fit.

What Elicit announced

  • 30 September 2026: new Alerts can no longer be created.
  • 31 October 2026: existing Alerts stop running unless they have been converted, and the Alerts page is removed. Papers already saved to your Elicit Library stay there.
  • The replacement is Routines. Elicit notes that, unlike Alerts, Routines count toward your monthly usage, because each run is agent work.
  • Converting is supported. An Alert can be converted into a Routine with the same research question, and an Alert's results can be exported to CSV.

Source: Elicit Help Center, “Elicit Alerts (Legacy Tool)”, read on 5 October 2026. Elicit may update its plans, so check the article for the latest details.

Before 31 October

Whatever you decide, a few minutes now keeps your history:

  • Export each Alert's results to CSV if you want a record of what it found. Elicit recommends doing this before 31 October.
  • Write down the question behind each Alert. It is the part worth keeping, whichever tool you use next.
  • Decide whether to convert or move. If you are staying with Elicit, converting an Alert to a Routine keeps the same question running, and the runs then count toward your Elicit usage.

What Research Monitor offers

Research Monitor works differently from a saved search. It may suit you if your work sits in one of the fields we cover.

Nightly monitoring of curated collections

Every night from 22:30 UTC we scan PubMed, bioRxiv, medRxiv, arXiv and OpenAlex for new papers in the collections you follow. New papers are scored for relevance and analysed by language models, and their findings are extracted.

Personalisation by your stated aim

Instead of a saved query, you answer a short research interview for each collection: your aim, your context, the evidence that would change your thinking, and what should get less attention. Only the aim is required. The papers whose findings come closest to your aim lead your Today page. The match is semantic, so it reflects relevance to your aim, not the quality of the study.

A free tier

The Free plan covers one collection, the interview and a personalised Today page. Paid plans add more collections, the daily AI brief and briefing emails: Researcher at $19 a month for academic and non-profit researchers, and Pro at $59 a month for industry. See plans and prices.

Agent access on every plan

If you work in Claude Code, Claude Desktop, Cursor or Codex, a read-only key lets your own agent search the collections you follow. Free includes 200 agent tool calls a month.

Where it may not fit

  • We monitor curated collections, not any search. They cover gut biology and mucosal immunology, spatial transcriptomics, single-cell foundation models and perturbation prediction, cancer cell therapy, immune engineering and synthetic biology, multi-omics integration, ML/AI methods, ML for biology, and sphingolipid signalling in immune cells. If your Alerts covered something else, we probably don't monitor it yet.
  • Email needs a paid plan. On Free, your matched papers are on your Today page in the app. On paid plans, the daily email covers the collections you follow, while your aim shapes the Today page and the daily AI brief.
  • Full text depends on the licence. We show full text and figures only when a paper's licence permits reuse, such as CC BY. Otherwise you see the abstract, the extracted findings and a link to the source.

Moving a question over

  1. Create a free account and choose the collection closest to your old Alert.
  2. Turn the Alert's question into an aim. A query says which words to match; an aim says what you are trying to understand. For example, the query IL-15 intraepithelial lymphocytes celiac becomes the aim understand how IL-15 licenses intraepithelial lymphocytes to kill the epithelium in celiac disease.
  3. If you like, answer the other three questions: your context, the evidence that would change your thinking, and what should get less attention.
  4. Open Today each morning. The papers closest to your aim come first.

Bring your question.

Start free with one collection. No card needed.

Elicit is a trademark of its owner. Research Monitor is independent and is not affiliated with or endorsed by Elicit.